Christian E. Gross - Publications

Affiliations: 
Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 
Area:
neurodegenerative disorders

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 D'Souza MJ, Kashmar RJ, Hurst K, Fiedler F, Gross CE, Deol JK, Wilson A. Integrative Biological Chemistry Program Includes The Use Of Informatics Tools, GIS And SAS Software Applications. Contemporary Issues in Education Research (Littleton, Colo.). 8: 193-214. PMID 26191337  1
2014 Bastide MF, de la Crompe B, Doudnikoff E, Fernagut PO, Gross CE, Mallet N, Boraud T, Bézard E. Inhibiting Lateral Habenula Improves L-DOPA-induced Dyskinesia. Biological Psychiatry. PMID 25442003 DOI: 10.1016/j.biopsych.2014.08.022  1
2014 Engeln M, Bastide MF, Toulmé E, Dehay B, Bourdenx M, Doudnikoff E, Li Q, Gross CE, Boué-Grabot E, Pisani A, Bezard E, Fernagut PO. Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-Dopa-Induced Dyskinesia. Biological Psychiatry. PMID 25146322 DOI: 10.1016/j.biopsych.2014.07.007  1
2014 Etienne S, Guthrie M, Goillandeau M, Nguyen TH, Orignac H, Gross C, Boraud T. Easy rider: monkeys learn to drive a wheelchair to navigate through a complex maze. Plos One. 9: e96275. PMID 24831130 DOI: 10.1371/journal.pone.0096275  0.92
2014 Bastide MF, Dovero S, Charron G, Porras G, Gross CE, Fernagut PO, Bézard E. Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiology of Disease. 62: 179-92. PMID 24103779 DOI: 10.1016/j.nbd.2013.09.020  1
2014 Larrue F, Sauzeon H, Wallet G, Foloppe D, Cazalets JR, Gross C, N'Kaoua B. Influence of body-centered information on the transfer of spatial learning from a virtual to a real environment Journal of Cognitive Psychology. 26: 906-918. DOI: 10.1080/20445911.2014.965714  0.72
2013 Chetrit J, Taupignon A, Froux L, Morin S, Bouali-Benazzouz R, Naudet F, Kadiri N, Gross CE, Bioulac B, Benazzouz A. Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 14840-9. PMID 24027284 DOI: 10.1523/JNEUROSCI.0453-13.2013  1
2013 Taillade M, Sauzéon H, Arvind Pala P, Déjos M, Larrue F, Gross C, N'Kaoua B. Age-related wayfinding differences in real large-scale environments: detrimental motor control effects during spatial learning are mediated by executive decline? Plos One. 8: e67193. PMID 23843992 DOI: 10.1371/journal.pone.0067193  0.6
2013 Taillade M, Sauzéon H, Dejos M, Pala PA, Larrue F, Wallet G, Gross C, N'Kaoua B. Executive and memory correlates of age-related differences in wayfinding performances using a virtual reality application. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 20: 298-319. PMID 22901081 DOI: 10.1080/13825585.2012.706247  0.6
2013 Larrue F, Sauzéon H, Foloppe D, Wallet G, Cazalets JR, Gross C, Hachet M, N'Kaoua B. Assessing the impact of automatic vs. controlled rotations on spatial transfer with a joystick and a walking interface in VR Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 8117: 1-18. DOI: 10.1007/978-3-642-40483-2_1  0.72
2012 Syed EC, Benazzouz A, Taillade M, Baufreton J, Champeaux K, Falgairolle M, Bioulac B, Gross CE, Boraud T. Oscillatory entrainment of subthalamic nucleus neurons and behavioural consequences in rodents and primates. The European Journal of Neuroscience. 36: 3246-57. PMID 22853738 DOI: 10.1111/j.1460-9568.2012.08246.x  1
2012 Dejean C, Nadjar A, Le Moine C, Bioulac B, Gross CE, Boraud T. Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats. Neurobiology of Disease. 46: 402-13. PMID 22353564 DOI: 10.1016/j.nbd.2012.02.004  1
2012 Pró-Sistiaga P, Lamberton F, Boraud T, Saulnier R, Young AR, Bioulac B, Gross C, Mazoyer B. High resolution 3T fMRI in anesthetized monkeys. Journal of Neuroscience Methods. 205: 86-95. PMID 22230769 DOI: 10.1016/j.jneumeth.2011.12.023  0.92
2011 Navailles S, Bioulac B, Gross C, De Deurwaerdère P. Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease. Neurobiology of Disease. 41: 585-90. PMID 21092759 DOI: 10.1016/j.nbd.2010.11.007  0.92
2010 Storvik M, Arguel MJ, Schmieder S, Delerue-Audegond A, Li Q, Qin C, Vital A, Bioulac B, Gross CE, Wong G, Nahon JL, Bezard E. Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex. Neurobiology of Disease. 38: 386-94. PMID 20206263 DOI: 10.1016/j.nbd.2010.02.008  1
2010 Navailles S, Benazzouz A, Bioulac B, Gross C, De Deurwaerdère P. High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2356-64. PMID 20147561 DOI: 10.1523/JNEUROSCI.5031-09.2010  0.92
2010 Navailles S, Bioulac B, Gross C, De Deurwaerdère P. Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease. Neurobiology of Disease. 38: 136-43. PMID 20096781 DOI: 10.1016/j.nbd.2010.01.012  0.92
2009 Chetrit J, Ballion B, Laquitaine S, Belujon P, Morin S, Taupignon A, Bioulac B, Gross CE, Benazzouz A. Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychotics. Plos One. 4: e6208. PMID 19587792 DOI: 10.1371/journal.pone.0006208  1
2009 Berton O, Guigoni C, Li Q, Bioulac BH, Aubert I, Gross CE, Dileone RJ, Nestler EJ, Bezard E. Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease. Biological Psychiatry. 66: 554-61. PMID 19481198 DOI: 10.1016/j.biopsych.2009.04.005  1
2008 Dejean C, Gross CE, Bioulac B, Boraud T. Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. Journal of Neurophysiology. 100: 385-96. PMID 18497362 DOI: 10.1152/jn.90466.2008  1
2008 Pioli EY, Meissner W, Sohr R, Gross CE, Bezard E, Bioulac BH. Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats. Neuroscience. 153: 1213-24. PMID 18455318 DOI: 10.1016/j.neuroscience.2008.01.084  1
2007 Leblois A, Meissner W, Bioulac B, Gross CE, Hansel D, Boraud T. Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. The European Journal of Neuroscience. 26: 1701-13. PMID 17880401 DOI: 10.1111/j.1460-9568.2007.05777.x  1
2007 Meissner W, Guigoni C, Cirilli L, Garret M, Bioulac BH, Gross CE, Bezard E, Benazzouz A. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease. The European Journal of Neuroscience. 25: 1492-500. PMID 17425575 DOI: 10.1111/j.1460-9568.2007.05406.x  1
2007 Dejean C, Gross CE, Bioulac B, Boraud T. Synchronous high-voltage spindles in the cortex-basal ganglia network of awake and unrestrained rats. The European Journal of Neuroscience. 25: 772-84. PMID 17313572 DOI: 10.1111/j.1460-9568.2007.05305.x  1
2007 Pasquereau B, Nadjar A, Arkadir D, Bezard E, Goillandeau M, Bioulac B, Gross CE, Boraud T. Shaping of motor responses by incentive values through the basal ganglia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1176-83. PMID 17267573 DOI: 10.1523/JNEUROSCI.3745-06.2007  1
2007 Aubert I, Guigoni C, Li Q, Dovero S, Bioulac BH, Gross CE, Crossman AR, Bloch B, Bezard E. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biological Psychiatry. 61: 836-44. PMID 16950226 DOI: 10.1016/j.biopsych.2006.06.038  1
2006 Leblois A, Meissner W, Bezard E, Bioulac B, Gross CE, Boraud T. Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys. The European Journal of Neuroscience. 24: 1201-8. PMID 16930445 DOI: 10.1111/j.1460-9568.2006.04984.x  1
2006 Guehl D, Cuny E, Benazzouz A, Rougier A, Tison F, Machado S, Grabot D, Gross C, Bioulac B, Burbaud P. Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 13: 963-71. PMID 16930362 DOI: 10.1111/j.1468-1331.2006.01405.x  0.92
2006 Sokoloff P, Diaz J, Le Foll B, Guillin O, Leriche L, Bezard E, Gross C. The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. Cns & Neurological Disorders Drug Targets. 5: 25-43. PMID 16613552 DOI: 10.2174/187152706784111551  0.72
2006 Bezard E, Gerlach I, Moratalla R, Gross CE, Jork R. 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiology of Disease. 23: 77-86. PMID 16545572 DOI: 10.1016/j.nbd.2006.02.003  1
2006 Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, Klitgaard H, Bioulac B, Gross CE, Bezard E, Boraud T. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiology of Disease. 22: 586-98. PMID 16531050 DOI: 10.1016/j.nbd.2006.01.009  1
2005 Bassilana F, Mace N, Li Q, Stutzmann JM, Gross CE, Pradier L, Benavides J, Ménager J, Bezard E. Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease. Neurobiology of Disease. 20: 93-103. PMID 16137570 DOI: 10.1016/j.nbd.2005.02.005  1
2005 Meissner W, Leblois A, Hansel D, Bioulac B, Gross CE, Benazzouz A, Boraud T. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain : a Journal of Neurology. 128: 2372-82. PMID 16123144 DOI: 10.1093/brain/awh616  1
2005 Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. The European Journal of Neuroscience. 22: 283-7. PMID 16029219 DOI: 10.1111/j.1460-9568.2005.04196.x  1
2005 Philip P, Gross CE, Taillard J, Bioulac B, Guilleminault C. An animal model of a spontaneously reversible obstructive sleep apnea syndrome in the monkey. Neurobiology of Disease. 20: 428-31. PMID 15886006 DOI: 10.1016/j.nbd.2005.03.024  1
2005 Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, HÃ¥kansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, et al. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism & Related Disorders. 11: S25-9. PMID 15885624 DOI: 10.1016/j.parkreldis.2004.11.005  1
2005 Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, Crossman AR, Gross CE, Bezard E. Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2102-7. PMID 15728850 DOI: 10.1523/JNEUROSCI.5059-04.2005  1
2005 Bezard E, Gross CE, Qin L, Gurevich VV, Benovic JL, Gurevich EV. L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiology of Disease. 18: 323-35. PMID 15686961 DOI: 10.1016/j.nbd.2004.10.005  1
2005 Aubert I, Guigoni C, HÃ¥kansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Annals of Neurology. 57: 17-26. PMID 15514976 DOI: 10.1002/ana.20296  1
2004 Pioli EY, Dovero S, Bioulac BH, Gross CE, Bezard E. Asymmetrically lesioned mesencephalon in healthy rodents: call for caution. Brain Research. 1022: 251-3. PMID 15353237 DOI: 10.1016/j.brainres.2004.07.014  1
2004 Pioli E, Sohr R, Meissner W, Barthe N, Gross CE, Bezard E, Bioulac BH. Partial bilateral mesencephalic lesions affect D1 but not D2 binding in both the striatum and cortex. Neurochemistry International. 45: 995-1004. PMID 15337298 DOI: 10.1016/j.neuint.2004.06.003  1
2004 Diguet E, Gross CE, Tison F, Bezard E. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Experimental Neurology. 189: 1-4. PMID 15296829 DOI: 10.1016/j.expneurol.2004.05.016  1
2004 Meissner W, Gross CE, Harnack D, Bioulac B, Benazzouz A. Deep brain stimulation for Parkinson's disease: Potential risk of tissue damage associated with external stimulation--erratum. Annals of Neurology. 56: 309-10. PMID 15293291 DOI: 10.1002/ana.20191  0.92
2004 Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. The European Journal of Neuroscience. 19: 3266-76. PMID 15217383 DOI: 10.1111/j.0953-816X.2004.03372.x  0.72
2004 Meissner W, Hill MP, Tison F, Gross CE, Bezard E. Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends in Pharmacological Sciences. 25: 249-53. PMID 15120490 DOI: 10.1016/j.tips.2004.03.003  1
2004 Obeso JA, Rodriguez-Oroz MC, Lanciego JL, Rodriguez Diaz M. How does Parkinson's disease begin? The role of compensatory mechanisms. Trends in Neurosciences. 27: 125-7; author reply . PMID 15036875 DOI: 10.1016/j.tins.2003.12.006  1
2004 Guillin O, Griffon N, Diaz J, Le Foll B, Bezard E, Gross C, Lammers C, Stark H, Carroll P, Schwartz JC, Sokoloff P. Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. International Review of Neurobiology. 59: 425-44. PMID 15006497 DOI: 10.1016/S0074-7742(04)59016-5  0.72
2004 Meissner W, Gross CE, Harnack D, Bioulac B, Benazzouz A. Deep brain stimulation for Parkinson's disease: potential risk of tissue damage associated with external stimulation. Annals of Neurology. 55: 449-50. PMID 14991830 DOI: 10.1002/ana.20002  1
2004 Diguet E, Gross CE, Bezard E, Tison F, Stefanova N, Wenning GK. Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment. Neurology. 62: 158; author reply 15. PMID 14718729  1
2004 Benazzouz A, Tai CH, Meissner W, Bioulac B, Bezard E, Gross C. High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 528-30. PMID 14715698 DOI: 10.1096/fj.03-0576fje  0.92
2004 Bioulac B, Burbaud P, Cazalets JR, Gross C. Motor functions | Fonctions motrices Emc - Neurologie. 1: 277-329. DOI: 10.1016/j.emcn.2004.02.002  0.92
2003 Hadj Tahar A, Bézard E, Grondin R, Gross CE, Bédard PJ. [Pathophysiology and therapy of L-Dopa-induced dyskinesia]. Revue Neurologique. 159: 1125-42. PMID 14978413  1
2003 Meissner W, Prunier C, Guilloteau D, Chalon S, Gross CE, Bezard E. Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. Molecular Neurobiology. 28: 209-18. PMID 14709785 DOI: 10.1385/MN:28:3:209  1
2003 Bezard E, Dovero S, Belin D, Duconger S, Jackson-Lewis V, Przedborski S, Piazza PV, Gross CE, Jaber M. Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10999-1007. PMID 14657156  1
2003 Guillin O, Griffon N, Bezard E, Leriche L, Diaz J, Gross C, Sokoloff P. Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. European Journal of Pharmacology. 480: 89-95. PMID 14623353 DOI: 10.1016/j.ejphar.2003.08.096  0.72
2003 Tai CH, Boraud T, Bezard E, Bioulac B, Gross C, Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1820-30. PMID 14519661 DOI: 10.1096/fj.03-0163com  0.92
2003 Prunier C, Bézard E, Montharu J, Mantzarides M, Besnard JC, Baulieu JL, Gross C, Guilloteau D, Chalon S. Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT. Neuroimage. 19: 810-6. PMID 12880809 DOI: 10.1016/S1053-8119(03)00163-0  0.72
2003 Meissner W, Dovero S, Bioulac B, Gross CE, Bezard E. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiology of Disease. 13: 46-54. PMID 12758066 DOI: 10.1016/S0969-9961(03)00011-1  1
2003 Bézard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross C, Sokoloff P. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nature Medicine. 9: 762-7. PMID 12740572 DOI: 10.1038/nm875  0.92
2003 Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends in Neurosciences. 26: 215-21. PMID 12689773 DOI: 10.1016/S0166-2236(03)00038-9  1
2003 Pioli EY, Gross CE, Meissner W, Bioulac BH, Bezard E. The deafferented nonhuman primate is not a reliable model of intractable pain. Neurological Research. 25: 127-9. PMID 12635510 DOI: 10.1179/016164103101201274  1
2003 Gross CE, Ravenscroft P, Dovero S, Jaber M, Bioulac B, Bezard E. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice. Journal of Neurochemistry. 84: 1246-55. PMID 12614325 DOI: 10.1046/j.1471-4159.2003.01600.x  1
2002 Cuny E, Guehl D, Burbaud P, Gross C, Dousset V, Rougier A. Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. Journal of Neurosurgery. 97: 591-7. PMID 12296643 DOI: 10.3171/jns.2002.97.3.0591  0.8
2002 Boraud T, Bezard E, Bioulac B, Gross CE. From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Progress in Neurobiology. 66: 265-83. PMID 11960681 DOI: 10.1016/S0301-0082(01)00033-8  1
2002 Burbaud P, Rougier A, Ferrer X, Guehl D, Cuny E, Arne P, Gross Ch, Bioulac B. Improvement of severe trunk spasms by bilateral high-frequency stimulation of the motor thalamus in a patient with chorea-acanthocytosis. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 204-7. PMID 11835468 DOI: 10.1002/mds.1260  0.92
2001 Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 6853-61. PMID 11517273  1
2001 Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nature Reviews. Neuroscience. 2: 577-88. PMID 11484001 DOI: 10.1038/35086062  1
2001 Bezard E, Boraud T, Chalon S, Brotchie JM, Guilloteau D, Gross CE. Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey. Neuroscience. 103: 117-23. PMID 11311792 DOI: 10.1016/S0306-4522(00)00546-7  1
2001 Bezard E, Ravenscroft P, Gross CE, Crossman AR, Brotchie JM. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys. Neurobiology of Disease. 8: 343-50. PMID 11300729 DOI: 10.1006/nbdi.2000.0375  1
2001 Bezard E, Crossman AR, Gross CE, Brotchie JM. Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1092-4. PMID 11292678  1
2001 Boraud T, Bezard E, Bioulac B, Gross CE. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain : a Journal of Neurology. 124: 546-57. PMID 11222455  1
2001 Beuter A, Titcombe MS, Richer F, Gross C, Guehl D. Effect of deep brain stimulation on amplitude and frequency characteristics of rest tremor in Parkinson's disease Thalamus and Related Systems. 1: 203-211. DOI: 10.1016/S1472-9288(01)00020-6  0.8
2000 Bezard E, Dovero S, Imbert C, Boraud T, Gross CE. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse (New York, N.Y.). 38: 363-8. PMID 11020240 DOI: 10.1002/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A  1
2000 Bezard E, Jaber M, Gonon F, Boireau A, Bloch B, Gross CE. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. The European Journal of Neuroscience. 12: 2892-900. PMID 10971632 DOI: 10.1046/j.1460-9568.2000.00180.x  1
2000 Boraud T, Bezard E, Bioulac B, Gross CE. Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey. Journal of Neurophysiology. 83: 1760-3. PMID 10712496  1
2000 Boraud T, Bezard E, Stutzmann JM, Bioulac B, Gross CE. Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey. Neuroscience Letters. 281: 75-8. PMID 10704746 DOI: 10.1016/S0304-3940(00)00780-1  1
2000 Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE. Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. Journal of Neuroscience Methods. 96: 71-6. PMID 10704673 DOI: 10.1016/S0165-0270(99)00184-3  1
1999 Bezard E, Brefel C, Tison F, Peyro-Saint-Paul H, Ladure P, Rascol O, Gross CE. Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 23: 1237-46. PMID 10581645 DOI: 10.1016/S0278-5846(99)00067-6  1
1999 Gross CE, Boraud T, Guehl D, Bioulac B, Bezard E. From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research? Progress in Neurobiology. 59: 509-32. PMID 10515666 DOI: 10.1016/S0301-0082(99)00015-5  1
1999 Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C. Trichloroethylene and parkinsonism: a human and experimental observation. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 6: 609-11. PMID 10457397  1
1999 Bezard E, Boraud T, Nguyen JP, Velasco F, Keravel Y, Gross C. Cortical stimulation and epileptic seizure: a study of the potential risk in primates. Neurosurgery. 45: 346-50. PMID 10449080 DOI: 10.1097/00006123-199908000-00030  0.92
1999 Bioulac B, Seal J, Guehl D, Burbaud P, Gross C. Reorganization of area 5 neuron activity in trained deafferented monkeys. Brain Research. 835: 266-74. PMID 10415382 DOI: 10.1016/S0006-8993(99)01609-1  0.92
1999 Bezard E, Boraud T, Bioulac B, Gross CE. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. The European Journal of Neuroscience. 11: 2167-70. PMID 10336685 DOI: 10.1046/j.1460-9568.1999.00627.x  1
1999 Bezard E, Gross CE, Fournier MC, Dovero S, Bloch B, Jaber M. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Experimental Neurology. 155: 268-73. PMID 10072302 DOI: 10.1006/exnr.1998.6995  1
1998 Bezard E, Stutzmann JM, Imbert C, Boraud T, Boireau A, Gross CE. Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model. European Journal of Pharmacology. 356: 101-4. PMID 9774238 DOI: 10.1016/S0014-2999(98)00537-8  1
1998 Bezard E, Imbert C, Gross CE. Experimental models of Parkinson's disease: from the static to the dynamic. Reviews in the Neurosciences. 9: 71-90. PMID 9711900  1
1998 Bezard E, Bioulac B, Gross CE. Glutamatergic compensatory mechanisms in experimental parkinsonism. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 22: 609-23. PMID 9682276 DOI: 10.1016/S0278-5846(98)00030-X  1
1998 Bezard E, Gross CE. Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Progress in Neurobiology. 55: 93-116. PMID 9618745 DOI: 10.1016/S0301-0082(98)00006-9  1
1998 Boraud T, Bezard E, Guehl D, Bioulac B, Gross C. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Research. 787: 157-60. PMID 9518590 DOI: 10.1016/S0006-8993(97)01563-1  0.92
1998 Bezard E, Boraud T, Imbert C, Dovero S, Bioulac B, Gross CE. Towards a dynamic approach of experimental parkinsonism Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22: 1317-1329. DOI: 10.1016/S0278-5846(98)00072-4  1
1997 Bezard E, Dovero S, Bioulac B, Gross C. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Experimental Neurology. 148: 288-92. PMID 9398471 DOI: 10.1006/exnr.1997.6648  1
1997 Bezard E, Imbert C, Deloire X, Bioulac B, Gross CE. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey. Brain Research. 766: 107-12. PMID 9359593 DOI: 10.1016/S0006-8993(97)00531-3  1
1997 Bezard E, Dovero S, Bioulac B, Gross CE. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Neuroscience Letters. 234: 47-50. PMID 9347943 DOI: 10.1016/S0304-3940(97)00663-0  1
1997 Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. Journal of Neurosurgery. 87: 491-8. PMID 9322838 DOI: 10.3171/jns.1997.87.4.0491  0.92
1997 Bezard E, Boraud T, Bioulac B, Gross CE. Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism. Neuroscience. 81: 399-404. PMID 9300430 DOI: 10.1016/S0306-4522(97)00226-1  1
1997 Beurrier C, Bezard E, Bioulac B, Gross C. Subthalamic stimulation elicits hemiballismus in normal monkey. Neuroreport. 8: 1625-9. PMID 9189903  0.92
1997 Bioulac B, Benazzouz A, Burbaud P, Gross C. Chronic administration of DL-allyl-glycine into the neostriatum, disorganises the firing modes of the nigral dopaminergic neurons in the rat. Neuroscience Letters. 226: 21-4. PMID 9153632 DOI: 10.1016/S0304-3940(97)00236-X  0.92
1997 Bezard E, Boraud T, Bioulac B, Gross CE. Presymptomatic revelation of experimental parkinsonism. Neuroreport. 8: 435-8. PMID 9080424  1
1981 Gross CE, DeKock JR, Panje WR, Hershkowitz N, Newman J. Evidence for orbital deformation that may contribute to monocular blindness following minor frontal head trauma. Journal of Neurosurgery. 55: 963-6. PMID 7299470 DOI: 10.3171/jns.1981.55.6.0963  1
Show low-probability matches.